Employment Verification
for Apellis Pharmaceuticals.
Fast, secure, and automated employment verification for Apellis Pharmaceuticals employees.
$39.99 per verification
Pay only when it worksAbout Apellis Pharmaceuticals
Apellis Pharmaceuticals is a biopharmaceutical company that develops therapies to treat various diseases caused by dysregulated activation of the complement system, a part of the immune system. Founded in 2009 and headquartered in Waltham, Massachusetts, Apellis Pharmaceuticals has developed a platform technology that targets C3, a central protein in the complement system. The company’s lead product candidate, pegcetacoplan, is a targeted inhibitor of C3 that is being developed for the treatment of several complement-mediated diseases, including paroxysmal nocturnal hemoglobinuria (PNH), geographic atrophy (GA), and C3 glomerulopathy (C3G). In addition to pegcetacoplan, Apellis Pharmaceuticals is also developing APL-9, an oral small molecule inhibitor of complement factor B for the treatment of complement-dependent diseases. Apellis Pharmaceuticals has collaborations with numerous pharmaceutical companies and research institutions, including AstraZeneca, the University of Pennsylvania, and the National Institutes of Health. The company has also received significant investment from venture capital firms and public offerings. As of 2021, Apellis Pharmaceuticals had a market capitalization of several billion dollars and employed over 200 individuals across its various locations. The company is committed to developing innovative therapies for patients with unmet medical needs caused by complement-mediated diseases.
The information on this page is not an endorsement of Truv’s services by Apellis Pharmaceuticals and is meant to be purely informational.
Verify Apellis Pharmaceuticals Employees
- Fast and automated verification: Most employment and income verifications are completed in under 24 hours.
- Secure and reliable: Truv is SOC2 TYPEII Compliant. Certified for Fannie Mae’s Day 1 Certainty® and Freddie Mac’s AIM®.
- Cost-effective pricing: Pay only for successful verifications and save up to 50% compared to competitors.
Category
BiotechnologyNumber of employees
200.0 – 500.0
Information sourced from public company data.
Apellis Pharmaceuticals Employment Verification FAQs.
You can verify employment for Apellis Pharmaceuticals employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Apellis Pharmaceuticals and many other employers.
Yes, Truv offers both employment and income verification services for Apellis Pharmaceuticals employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasize security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include Shimadzu Scientific Instruments, Sangamo Therapeutics and Novozymes.
No, the information provided about Truv’s verification services is not an endorsement by the Apellis Pharmaceuticals.
Not the employer you were looking for?
Also verified with Truv
About Apellis Pharmaceuticals
Apellis Pharmaceuticals is a biopharmaceutical company that develops therapies to treat various diseases caused by dysregulated activation of the complement system, a part of the immune system. Founded in 2009 and headquartered in Waltham, Massachusetts, Apellis Pharmaceuticals has developed a platform technology that targets C3, a central protein in the complement system. The company’s lead product candidate, pegcetacoplan, is a targeted inhibitor of C3 that is being developed for the treatment of several complement-mediated diseases, including paroxysmal nocturnal hemoglobinuria (PNH), geographic atrophy (GA), and C3 glomerulopathy (C3G). In addition to pegcetacoplan, Apellis Pharmaceuticals is also developing APL-9, an oral small molecule inhibitor of complement factor B for the treatment of complement-dependent diseases. Apellis Pharmaceuticals has collaborations with numerous pharmaceutical companies and research institutions, including AstraZeneca, the University of Pennsylvania, and the National Institutes of Health. The company has also received significant investment from venture capital firms and public offerings. As of 2021, Apellis Pharmaceuticals had a market capitalization of several billion dollars and employed over 200 individuals across its various locations. The company is committed to developing innovative therapies for patients with unmet medical needs caused by complement-mediated diseases.
The information on this page is not an endorsement of Truv’s services by Apellis Pharmaceuticals and is meant to be purely informational.
Verify Apellis Pharmaceuticals Employees
Truv provides quick, secure and cost-effective employment and income verifications for thousands of verifiers. The process is simple and automated and most employees are verified in under 24 hours. You only pay for successful verification and can save on average 50% compared to competitors. Thousands of verifiers love Truv because it’s been never been easier and more streamlined to verify an employee. Learn more
Apellis Pharmaceuticals Employment Verification FAQ.
You can verify employment for Apellis Pharmaceuticals employees through Truv, a secure and automated verification service. Truv provides quick and cost-effective employment verifications for Apellis Pharmaceuticals and many other employers.
Yes, Truv offers both employment and income verification services for Apellis Pharmaceuticals employees. This service is designed to be comprehensive, covering both employment status and income information.
Most verifications through Truv are completed in under 24 hours.
Yes, we emphasizes security in our verification process. Truv provides secure and automated verifications to protect employee information.
Truv operates on a pay-per-success model, meaning you only pay for successful verifications. On average, users save about 50% compared to competitors’ services.
Yes, Truv provides verification services for various Biotechnology companies. Some examples mentioned include Shimadzu Scientific Instruments, Sangamo Therapeutics and Novozymes.
No, the information provided about Truv’s verification services is not an endorsement by the Apellis Pharmaceuticals.
Yes, Truv provides an option to « Start a verification » directly from this website for Apellis Pharmaceuticals employees and employees of many other organizations.